Interestingly, a reggie-mediated PM-stabilization of the tyrosine kinase receptor ErbB2, which is a predictor of poor prognosis in breast cancer patients, seems to be the upstream regulator of the Akt signaling in this cell line [88]. This evidence concerns the gene AKT1 and breast cancer.